Archive for the ‘Anaplasmosis’ Category

Podcast: Lyme Disease and Tick-Borne Co-infections

https://globallymealliance.org/podcast-lyme-disease-tick-borne-co-infections/

PODCAST: LYME DISEASE AND TICK-BORNE CO-INFECTIONS
January 17, 2017

The most common tick-borne infection is Lyme disease. However, infected ticks also carry and spread numerous co-infections.

The newest Global Lyme Alliance podcast, with GLA’s Dr. Harriet Kotsoris and Dr. Mayla Hsu, discusses Lyme disease and the co-infections that are often transmitted along with the initial tick bite. Below is an excerpt.  https://soundcloud.com/user-988784721/lyme-disease-and-tick-borne-co-infections  (Click on this link for the entire podcast or you can fast forward to 13:15 and it will pick up at Bartonella which is where the transcript stops below.  It also goes into viruses and STARI).

Host: In this podcast we’re going to expand our discussion to include co-infecting tick-borne diseases that are often transmitted along with Lyme. I’m in our studio with Dr. Harriet Kotsoris and Dr. Mayla Hsu who are science and research officers at the Global Lyme Alliance. I’ll start off by asking, what is a tick-borne infection?
Dr. Harriet Kotsoris: A tick-borne infection is an infectious disease spread by the bite of an infected tick. The most common is Lyme disease but many others are present in the same tick bite. Depending on the location and the season, up to half of all ticks may have had more than one kind of microbe or disease producing organism that can make humans very sick. The list of microbes is expanding up to 11 or 12 at last count, but we’ll focus today on the major ones. These are called co-infections, the simultaneous infection of a host by multiple pathogenic or disease producing organisms.
There is an increasing number of ticks that are multiply infected as we just said. In a recent west European study of Ixodes ricinus ticks, very similar to the American black legged deer tick, up to 45% of those ticks were co-infected with up to five pathogens or disease producing organisms. We have a similar experience here in the United States.
Host: How many people get tick-borne infections?
Dr. Kotsoris: The Centers for Disease Control calculates about 330,000 Lyme disease cases per year but it may be even over 400,000. It’s not really understood how many of these are also infected with other microbes, which in some cases cause different illnesses that require different diagnostic tests and different treatments.
Host: What can you tell us about the ticks that spread these diseases?
Dr. Mayla Hsu: Well in the United States there are different families of ticks that may be co-infected with various pathogens. As Harriet just mentioned, the Ixodes ticks or the black-legged ticks are now in half of all United States counties. There’s another tick that is further south, known as the Lone Star and there is also an American dog tick called Dermacentor that also harbors infectious microbes.
Host: How about internationally?
Dr. Hsu: Well it seems that ticks are generally found in all temperate climate zones, so there are the Ixodes species in North America, these are also found in Europe and Asia, there are other ticks found in Africa, parts of temperate Africa, that infect humans as well as animals there, and they’re responsible for causing relapsing fevers. There are soft ticks, Ornithodoros, the Ornithodoros family of ticks, that are found in South America and Western Africa, and these too are associated with causing diseases in humans. The jury is still out in Australia. There are ticks there but it’s not known whether or not they’re correlating with human disease.
Host: What do we know about changing tick geography?
Dr. Kotsoris: It seems that in the United States, the geographic range where ticks are found is expanding and we know that with climate change the range is also changing, so for instance, it is expanding northwards into Canada where Lyme disease was never a concern, it now is starting to emerge. We can expect and see more tick-borne diseases elsewhere, also spreading in through the United States. These are now classified as emerging infections and so public health authorities are very concerned about this and tracking the emergence of more tick-borne illnesses.
Host: What are some of the emerging tick-borne diseases and again we’re going to focus only on the major ones about which the most is known.
Dr. Hsu: One of the more interesting tick-borne illnesses that has been emerging in recent years is called babesiosis. This is an illness caused by a parasite that’s very similar to malaria. It’s called Babesia, Babesia microti. This is characterized by recurrent fevers, so people get fevers that spike and then go away and then come back over and over again, chills, muscle and joint aches and pains and it can be actually fatal in rare cases. The diagnostic test for this is not a blood test looking for antibodies, rather the blood is examined under a microscope and here you can see the organism actually growing in red blood cells, so just like malaria it grows in red blood cells and you can see it in a blood smear and the treatment required for this is also very similar to anti-malaria therapies, so that’s drugs that are similar to quinine but also anti-protozoan drugs like Atovaquone, also known as Mepron, and antibiotics, azithromycin and clindamycin.
About 1,800 people were reported to have gotten babesiosis in the year 2013, and the numbers are rising so where we see Lyme disease we are also starting to see more and more Babesia, and it’s important to point out that the treatment and diagnostic for Babesia is different from that of Lyme disease, so if Lyme disease is suspected and is looked for, and treated, a person who also has Babesia will not get adequately diagnosed or treated and can continue to be ill.
Host: There are several bacterial diseases that are spread by ticks that have been getting more attention in recent years, Anaplasma and Ehrlichia.
Dr. Kotsoris: Yes, historically these started out as veterinary diseases. They were identified in the late 80s and early 1990s, after having been studied as long-standing veterinary problems. These organisms belong to a group known as the Rickettsiae, Anaplasma, Ehrlichia, and Rickettsia itself. These are what we call obligate intracellular parasites. They’re bacteria that only live inside the cells of another organism, and that’s how they affect humans. Human granulocytic anaplasmosis is what we call a gram-negative bacterium of the rickettsia family. It invades white blood cells after a tick bite by an infected tick and it travels and lodges within granulocytes or the neutophils, the white blood cells of the human being.
About one to two weeks after the bite, the patient will develop spiking fevers, headache, drop in white blood count, drop in platelet count…the platelets are responsible for clotting blood, and a rise of liver function tests indicative of an inflammation of the liver. These organisms are very smart and release a chemical substance known as a chemokine, or a cytokine, interleukin-8 that actually is an attracting chemical for white blood cells to help propagate the infection throughout the body. The diagnosis has to be made by blood smear because the comparison of acute and convalescent sera that is the development of convalescent antibodies may be too late in the game, that the patient will have been compromised medically and treatment will have been delayed. The diagnosis can also be made by something known as polymerase chain reaction and the treatment is doxycycline, 100 milligrams twice a day, similar to what’s used in acute Lyme disease and the treatment is until three days after the disappearance of the fever.
Related is something known as human monocytic ehrlichiosis. Ehrlichia and Anaplasma were used interchangeably in the past, but now they’ve been divided into separate categories because of the bacterial composition. Human granulocytic anaplasmosis is carried by the black legged deer tick, Ixodes scapularis, Ixodes pacificus on the west coast, but this vector for human monocytic ehrlichiosis is the Lone star tick, or Amblyomma americanum and Dermacentor variabilis, the American dog tick. The classic infection in the Midwest in particular is by Ehrlichia chaffeensis and Ehrlichia ewingii, more so chaffeensis. Usually peaking in July, usually affecting males older than 50 years old, and again, within a few weeks of the tick bite, the patient develops headaches, muscle aches, otherwise known as myalgias, fatigue, a drop in white blood count, a drop in platelet count, fever, gastrointestinal systems, which may lead to also respiratory insufficiency and kidney failure.
The three states most affected by Ehrlichia chaffeensis and ewingii are Oklahoma, Missouri, and Arkansas. They account for 30% of the reported cases of these bacterial species. The numbers have been reported in the low thousands over the last few years. In 2009, a third cause of human ehrlichiosis was identified in the upper Midwest. This has been known as Ehrlichia muris-like agent. Interestingly, it also exists in Eastern Europe and Asia. The detection of this pathogen or disease producing organism is by looking for the DNA, that is the genetic material, of this organism in the blood of patients. About 2.5% of Ixodes scapularis ticks are infected by this E. muris type agent. Note that this one is spread by Ixodes scapularis, the black legged deer tick, not the Lone Star tick as in human monocytic ehrlichiosis.
One of the better known bacterial infections that people read about, hear about, especially with people traveling into the Rocky Mountain area, into the Midwest, into the Southeast, is something known as Rocky Mountain Spotted Fever. This is Rickettsia rickettsia…it is spread by the American dog tick, by the Rocky Mountain wood tick, and by the brown dog tick. There are reported 14 cases per million population, peaking in April through September. Despite its name, as I said before, it’s not confined to the Rocky Mountains, it’s also found in the southeastern United States. These bacteria, after the tick bite, travel within the blood stream and lodge within endothelial cells, that’s the lining cells of small blood vessels, and elicit inflammatory changes and make the blood vessels leaky, affecting all organs infected, especially the skin and the adrenal glands. The platelets responsible for clotting are consumed and you may have kidney malfunctioning.
Patient will present with severe headaches, high fevers, a few days after the bite and a few days after that, a spotted rash on the wrists, palms, and ankles. Patient may also have abdominal pain, nausea, vomiting, and other generalized symptoms. The mortality rate can be as high as 4% and this is caused by a delay in diagnosis and treatment. The treatment is doxycycline and patients do best, and have a much lower morbidity and mortality if they’re treated within five days of being infected.
Below is the full podcast with Dr. Kotsoris and Dr. Hsu. They continue their overview of Lyme and co-infections, specifically Bartonella and the Powassan virus.

Follow Global Lyme Alliance on SoundCloud to hear future podcasts.

Systematic Review: Human Diseases From Deer Ticks

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857413/#!po=47.6331

Mark P. Nelder,corresponding author Curtis B. Russell, Nina Jain Sheehan, Beate Sander, Stephen Moore, Ye Li, Steven Johnson, Samir N. Patel, and Doug Sider

I condensed information from the above link.

Abstract

Background

The blacklegged tick Ixodes scapularis transmits Borrelia burgdorferi (sensu stricto) in eastern North America; however, the agent of Lyme disease is not the sole pathogen harbored by the blacklegged tick. The blacklegged tick is expanding its range into areas of southern Canada such as Ontario, an area where exposure to blacklegged tick bites and tick-borne pathogens is increasing. We performed a systematic review to evaluate the public health risks posed by expanding blacklegged tick populations and their associated pathogens.

Methods

Researchers searched Ovid MEDLINE, Embase, BIOSIS, Scopus and Environment Complete databases for the years 2000 through 2015 using specific eligibility criteria such as field-collected backlegged ticks and studies that did NOT focus solely on B. burgdorferi (Bb) and performed quality assessments on eligible studies.  

Results

Seventy-eight studies were chosen.  The ticks in the studies harbored 91 distinct taxa, 16 of which are tick-transmitted human pathogens including Anaplasma, Babesia, Bartonella, Borrelia, Ehrlichia, Rickettsia, Theileria and Flavivirus.

Conclusions

Our review is the first systematic assessment of the literature on the human pathogens associated with the blacklegged tick. As Lyme disease awareness continues to increase, it is an opportune time to document the full spectrum of human pathogens transmittable by blacklegged ticks.

If you go to the link at the top of page, Table One in the study has an informative table that shows the various states the studies were derived from as well as the human infections they found.  For Wisconsin the following were found:

*Arboviral infection (encephalitis, meningitis)

*Anaplasmosis

*Babesiosis

*Lyme Disease

*Ehrlichiosis

*Rocky Mountain Spotted Fever

**Bartonella is NOT reportable, which we need to do something about.  Frankly, it is as nasty if not nastier than borrelia, and just as hard to get rid of.  Also, other borrelia species are also NOT reportable.  

***Also, just because it wasn’t found in this systemic review doesn’t mean it doesn’t exist.  

 

Bm & TBI’s in NY State

http://www.sciencedirect.com/science/article/pii/S1877959X17300158

Detection of Borrelia miyamotoi and other tick-borne pathogens in human clinical specimens and Ixodes scapularis ticks in New York State, 2012-2015.

Wroblewski D, Gebhardt L, Prusinski MA, Meehan LJ, Halse TA, Musser KA.

Ticks and Tick-borne Diseases, online first, 2017 Jan 16. pii: S1877-959X(17)30015-8.

Abstract

Borrelia miyamotoi (Bm) is a recently emerging bacterial agent transmitted by several species of ixodid ticks. Diagnosis of Bm infection can be challenging, as the organism is not easily cultivable.

We have developed and validated a multiplex real-time PCR to simultaneously identify Bm infection and the agents causing human granulocytic anaplasmosis and human monocytic ehrlichiosis, Anaplasma phagocytophilum and Ehrlichia chaffeensis, respectively. The assay is 100% specific; highly sensitive, detecting 11 gene copies of Bm DNA in both whole blood and cerebral spinal fluid; and provides rapid results in less than two hours.

A retrospective study of 796 clinical specimens collected between the years 2012 and 2014 and a prospective study of 366 clinical specimens were performed utilizing this novel assay to evaluate the frequency of Bm infection in New York State (NYS). Eight clinical specimens (1%) were found to be positive for Bm, 216 were positive for A. phagocytophilum, and 10 were positive for E. chaffeensis.

Additionally, we tested 411 I. scapularis ticks collected in NYS during 2013 and 2014 in a separate multiplex real-time PCR to determine the prevalence of Bm, A. phagocytophilum, Borrelia burgdorferi s.s., and Borrelia species. Our results indicated rates of 1.5%, 27%, 19.7%, and 8.8% respectively.

The ability to monitor both the frequency and geographic distribution of Bm cases and the prevalence and geographic distribution of Bm in ticks will help create a better understanding of this emerging tick-borne pathogen.

Promising Tick Research

https://www.eurekalert.org/pub_releases/2017-01/yu-hw011317.php

PUBLIC RELEASE: 16-JAN-2017

How ‘stealth warrior’ bacteria turn a tick’s gut microbes against itself

YALE UNIVERSITY

New Haven, Conn.– Before infecting humans, tick-borne bacteria or viruses first have to get past a tick’s defenses to colonize it. How this occurs is not well understood. To investigate, Yale researchers studied a model of the second-most-common tick-borne infection in the United States, human granulocytic anaplasmosis, which can cause headaches, muscle pain, and even death.
The researchers found that in ticks, the bacterium that causes the infection, A. phagocytophilum, triggers the expression of a particular protein. This protein alters molecules in the tick’s gut, allowing the bacteria to enter and colonize the gut microbes.

“It’s like a stealth warrior that indirectly changes the tick by using the tick’s own defense system,” said Erol Fikrig, M.D., chief of the Infectious Diseases Section at Yale School of Medicine and senior author of the study.

The unexpected finding could help scientists develop strategies to block A. phagocytophilum and other tick-borne agents that cause disease, say the researchers. Fikrig’s team will explore the phenomenon in the bacterium that causes Lyme disease, and its work could have implications for other mosquito-borne infections, such as Zika and West Nile.

The study was published by the Proceedings of the National Academy of Sciences.

Other authors are Nabil M. Abraham, Lei Liu, Brandon L. Jutras, Akhilesh K. Yadav, Sukanya Narasimhan, Vissagan Gopalakrishnan, Juliana M. Ansari, Kimberly K. Jefferson, Felipe Cava, and Christine Jacobs-Wagner.
This work was supported in part by a gift from the John Monsky and Jennifer Weis Monsky Lyme Disease Research Fund, by a National Institutes of Health grant, and by the Howard Hughes Medical Institute.

TBI’s Increasing and Spreading

Tick Borne Infections (TBI’s) were tested in 9 national parks in this study.

As a patient and advocate, I wish researchers would carefully choose their wording when reporting results.  For instance the authors state:  “Ba. microti occurred at just 20% of the parks.   http://jme.oxfordjournals.org/content/early/2016/12/28/jme.tjw213.  That wording will bias people into thinking it isn’t significant, but 20% is nothing to sniff at, particularly when you are one of the 20%.  Also, that is what they discovered.  Someone else may discover something else and if time is any indicator, that number will probably rise.  I would also like to see Bartonella strains added to the pathogen list.  Interesting to note: there are 210 cases of locally acquired Zika in the Continental U.S., yet Congress is considering appropriating billions of dollars toward it.   https://www.cdc.gov/zika/intheus/maps-zika-us.htmlhttp://www.usatoday.com/story/news/2016/01/28/who-warns-zika-spread/79451430/http://www.usatoday.com/story/news/politics/2016/05/25/zika-funding-mired-congress/84914934/

Abstract

Tick-borne pathogens transmitted by Ixodes scapularis Say (Acari: Ixodidae), also known as the deer tick or blacklegged tick, are increasing in incidence and geographic distribution in the United States. We examined the risk of tick-borne disease exposure in 9 national parks across six Northeastern and Mid-Atlantic States and the District of Columbia in 2014 and 2015. To assess the recreational risk to park visitors, we sampled for ticks along frequently used trails and calculated the density of I. scapularis nymphs (DON) and the density of infected nymphs (DIN). We determined the nymphal infection prevalence of I. scapularis with a suite of tick-borne pathogens including Borrelia burgdorferi, Borrelia miyamotoi, Anaplasma phagocytophilum, and Babesia microti. Ixodes scapularis nymphs were found in all national park units; DON ranged from 0.40 to 13.73 nymphs per 100 m2. Borrelia burgdorferi, the causative agent of Lyme disease, was found at all sites where I. scapularis was documented; DIN with B. burgdorferi ranged from 0.06 to 5.71 nymphs per 100 m2. Borrelia miyamotoi and A. phagocytophilum were documented at 60% and 70% of the parks, respectively, while Ba. microti occurred at just 20% of the parks. Ixodes scapularis is well established across much of the Northeastern and Mid-Atlantic States, and our results are generally consistent with previous studies conducted near the areas we sampled. Newly established I. scapularis populations were documented in two locations: Washington, D.C. (Rock Creek Park) and Greene County, Virginia (Shenandoah National Park). This research demonstrates the potential risk of tick-borne pathogen exposure in national parks and can be used to educate park visitors about the importance of preventative actions to minimize tick exposure.

In the eastern United States, the blacklegged tick, Ixodes scapularis Say, is the primary vector of Borrelia burgdorferi, the causative agent of Lyme disease, which is the most commonly reported vector-borne disease in the United States (Mead 2015). Ixodes scapularis also vectors other pathogens that can cause potentially serious disease, including Borrelia miyamotoi, Anaplasma phagocytophilum, and Babesia microti (Barbour and Fish 1993, Homer et al. 2000, Jin et al. 2012, Krause et al. 2015). Established blacklegged tick populations are nearly continuous across counties in the Northeastern and North-Central United States where the majority of I. scapularis-borne disease cases are reported (Mead 2015, Eisen et al. 2016). The risk of acquiring Lyme disease is influenced by spatio-temporal variation in the density of host-seeking infected nymphs (Diuk-Wasser et al. 2012). This metric often correlates with Lyme disease incidence, though to varying degrees (Mather et al. 1996, Stafford et al. 1998, Falco et al. 1999, Pepin et al. 2012). Human behavior, including time spent in tick-infested areas or engaged in behaviors that enhance or reduce the likelihood of encounters with ticks (Orloski et al. 2000, Connally et al. 2009), also influences the likelihood of acquiring Lyme disease and may explain some of the lack of concordance between measures of density of infected host-seeking nymphs and Lyme disease incidence (Pepin et al. 2012).

Understanding where people may come into contact with infected vector-competent ticks is central to mitigating tick-borne disease risk. For example, in the Mid-Atlantic and Northeastern United States, peridomestic exposure to I. scapularis likely occurs frequently (Falco and Fish 1988, Maupin et al. 1991, Klein et al. 1996, Connally et al. 2006, Feldman et al. 2015), whereas in the North-Central United States, recreational exposures are believed to be more common than peridomestic exposures (Kitron and Kazmierczak 1997, Paskewitz et al. 2001). Regardless of geographic region, previous studies have demonstrated a risk of human exposure to infected host-seeking I. scapularis nymphs in recreational settings (Falco and Fish 1989, Schulze et al. 1992, Oliver and Howard 1998, Paskewitz et al. 2001, Han et al. 2014, Prusinski et al. 2014, Ford et al. 2015). National parks are popular recreation destinations and may represent areas of elevated acarological risk, yet one cannot adequately infer the risk of tick-borne disease for park visitors or employees from the epidemiological surveillance conducted at the county spatial scale (Eisen et al. 2013). National parks often vary ecologically from surrounding areas, and thus the density of infected ticks may differ between settings; further, human behavior within the parks may differ from behavior in surrounding communities.

In this study, we sought to characterize the acarological risk, that is, the risk of human exposure to tick-borne pathogens, in national parks in the Eastern United States. We surveyed frequently used trails in national park units across six Northeastern and Mid-Atlantic States and the District of Columbia, ranging from Maine in the north to Virginia in the south. Our collection efforts focused on the nymphal stage of I. scapularis. This stage likely poses the greatest threat of transmission of B. burgdorferi and other pathogens to humans, as peak activity of questing nymphs occurs in late spring and early summer which coincides with peak onset of human disease (Piesman 1989, Fish 1993, Falco et al. 1999, Mead 2015). Here, we describe the diversity of ticks collected by drag sampling during summer months, density of host-seeking I. scapularis nymphs, and diversity and prevalence of B. burgdorferi, B. miyamotoi, A. phagocytophilum, and Ba. microti infection in I. scapularis nymphs.